Endra, Inc. SUBSCRIPTION AGREEMENTSubscription Agreement • August 9th, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • California
Contract Type FiledAugust 9th, 2016 Company Industry Jurisdiction
AMENDMENT TO SUBLICENSE AGREEMENTSublicense Agreement • August 9th, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus
Contract Type FiledAugust 9th, 2016 Company IndustryThis Amendment (“Amendment”) to the Sublicense Agreement dated as of August 2, 2007 (the “Agreement”) by and among Endra, Inc., a Delaware corporation (“Endra”), and Optosonics, Inc. (“Optosonics”) is entered into on this 18th day of January, 2011 (the “Amendment Effective Date”). For purposes hereof, all capitalized terms used herein but not defined herein shall have the meanings given to them in the Agreement.
PROMISSORY NOTEPromissory Note • August 9th, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus
Contract Type FiledAugust 9th, 2016 Company IndustryFOR VALUE RECEIVED, Endra, Inc., a Delaware corporation (“Borrower”), promises to pay to the order of ____________ (“Lender”) the principal sum of ________________ Dollars ($_______), or such other amount as shall have been advanced and be outstanding hereunder and remain unpaid, without interest thereon.
CONSULTING AGREEMENTConsulting Agreement • August 9th, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • California
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (the “Agreement”) is entered into as of July 23, 2014, by and between Endra, Inc., a Michigan corporation (the “Company”), and StoryCorp Consulting, a Nevada corporation (“StoryCorp”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 9th, 2016 • Endra Inc. • Electromedical & electrotherapeutic apparatus • California
Contract Type FiledAugust 9th, 2016 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”), dated as of July 10, 2013, is by and between PureTech Ventures, LLC, a Delaware limited liability corporation (the “Seller”), and each purchaser identified on Schedule A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).